| Chronic Obstructive Pulmonary Disease |
1 |
1 |
| Inhaled Corticosteroid |
0 |
0.56 |
| Asthma |
0 |
0.46 |
| Corticosteroids |
0 |
0.43 |
| Inhalers |
0 |
0.43 |
| Clinical Guidelines |
0 |
0.36 |
| Bronchodilator |
0 |
0.29 |
| Lung |
0 |
0.29 |
| Adverse Effects |
0 |
0.22 |
| Steroids |
0 |
0.22 |
| Pneumonia |
0 |
0.15 |
| Bone Density |
0 |
0.14 |
| Clinical Research |
0 |
0.14 |
| Immunocompromise |
0 |
0.14 |
| Patient Safety |
0 |
0.14 |
| Severe COPD |
0 |
0.14 |
| Statistics |
0 |
0.14 |
| Tobacco Use |
0 |
0.12 |
| Congestive Heart Failure |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Heart Failure (HF) |
0 |
0.08 |
| Airway |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Bone |
0 |
0.07 |
| Data Collection |
0 |
0.07 |
| Electronic Health Record (EHR) |
0 |
0.07 |
| Electronic Medical Record |
0 |
0.07 |
| Eosinophils |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Minerals |
0 |
0.07 |
| Shared Decision-Making |
0 |
0.07 |
| Texas |
0 |
0.07 |
| Tobacco Cessation |
0 |
0.07 |